Document is current
Any future updates will be listed below
-
Authors
Mickute, Gerda http://orcid.org/0000-0002-2477-7565
Staley, Kristina
Delaney, Heather
Gardiner, Oliver
Hunter, Amy
Keen, Richard
Lockhart, Lorraine
Meade, Nick
Newman, Maria
Ralston, Stuart
Rush, Elaine
Upadhyaya, Sheela
Regan, Sandra
Watts, Laura
Walsh, Jennifer
White, Paul
Francis, Roger M.
Javaid, M. Kassim
-
Funding
Funding for this research was provided by:
NIHR Oxford Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 31 March 2020
Accepted: 4 May 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: Following guidance published by JLA and NHS National Patient Safety Agency National Research Ethics Service, this work required no ethics approval.
: All authors give consent to publication.
: MKJ has received honoraria, unrestricted research grants, travel and/or subsistence expenses from: Mereo Biopharma and Kyowa Kirin Hakin. JW received speaker’s honoraria from Eli Lilly and Sandoz, grant funding from Alexion and Immunodiagnostic Systems, donation of drug from Eli Lilly, Prostrakan (Kyowa Kirin) and Consilient for clinical studies, donation of assay kits from Biomedica, consulting fees from Shire, Mereo Biopharma, Kyowa Kirin, UCB Pharma and PharmaCosmos. JW is also a local PI and TSC member for Topaz study as well as a DMC member for Asteroid study. RK is a member of advisory board for the UK Brittle Bone Society and Kyowa Kirin, has received research support from Kyowa Kirin and Mereo BioPharma as well as consultancy fees from Kyowa Kirin.
